quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:00:00·1913d
PRRelease
Biohaven Ltd. logo
Ascendis Pharma A/S logo
KalVista Pharmaceuticals Inc. logo
+3

Frazier Healthcare Partners Adds Highly Experienced Investor to Life Sciences Team

BHVN· Biohaven Ltd.ASND· Ascendis Pharma A/SKALV· KalVista Pharmaceuticals Inc.SRRA· Sierra Oncology Inc.MNLO· Menlo Therapeutics Inc.ACRS· Aclaris Therapeutics Inc.
Health Care
Original source

Companies

  • BHVN
    Biohaven Ltd.
    Health Care
  • ASND
    Ascendis Pharma A/S
    Health Care
  • KALV
    KalVista Pharmaceuticals Inc.
    Health Care
  • SRRA
    Sierra Oncology Inc.
    Health Care
  • MNLO
    Menlo Therapeutics Inc.
    Health Care
  • ACRS
    Aclaris Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Apr 16ACRSUpdateOppenheimer$10.00
  • Apr 13BHVNUpdateCanaccord Genuity$21.00
  • Mar 16ASNDUpdateJefferies-
  • Feb 6BHVNUpdateGoldman$23.00
  • Jan 28ASNDUpdateBarclays$342.00
  • Jan 21BHVNUpdateRBC Capital Mkts$22.00

Related

  • SEC20h
    SEC Form DEFA14A filed by Aclaris Therapeutics Inc.
  • SEC20h
    SEC Form DEF 14A filed by Aclaris Therapeutics Inc.
  • SEC2d
    SEC Form 6-K filed by Ascendis Pharma A/S
  • PR2d
    Ascendis Announces Redemption of All $575 Million of Outstanding 2.25% Convertible Senior Notes Due 2028
  • SEC2d
    SEC Form 6-K filed by Ascendis Pharma A/S
  • INSIDER3d
    SEC Form 4 filed by Audhya Paul K.
  • INSIDER3d
    SEC Form 4 filed by Sweeny Nicole
  • INSIDER3d
    SEC Form 4 filed by Piekos Brian
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022